A few days ago, the "Long-term Storage and Resuscitation Cultivation of Immune Cell Technology" project jointly completed by Yang Baofeng, an academician of the Chinese Academy of Engineering, and Heilongjiang Tianqing Stem Cell Co., Ltd. passed the results of the identification. Key technologies such as the establishment of the curve and independent research on cell cryopreservation solutions have reached the international advanced level of similar research. Many technologies have filled the domestic gaps. It is recommended to further promote and apply at home and abroad. The expert group believes that the technological transformation of the project has broad prospects in autologous tumor immunotherapy, immune enhancement of sub-healthy populations, and anti-aging.
It is reported that the use of biological immune technology to treat tumors has the characteristics of good efficacy, safety and reliability, but there are problems with the immune cells of tumor patients themselves, and the efficacy of these problematic immune cells to treat tumors is extremely unstable. There are new problems such as safety when using allogeneic healthy human immune cells. The best way is for people to store their healthy immune cells when they are healthy. Once they are sick, they can use these stored healthy immune cells to treat, and the effect will be significantly improved. According to review experts, after the application and promotion of this technology, humans will be able to store the immune cells that have strong vitality when they are young and healthy, and they will be able to enhance their own immunity through clinical reinfusion treatment when their immunity is reduced or the body is in a sub-healthy state. , Alleviate the effect of sub-health state; after suffering from cancer, biological immune cell therapy can also be used to inject the viable immune cells stored at a young age into the body to activate the patient’s immune system and target the cancer cells in the patient’s body. To the purpose of treating tumors.